ArisiTol: Latest News

[...] A. CASSIDY | Associated Press AUGUSTA, Ga. (AP) — Georgia's governor is pushing clinical trials for a marijuana-derived drug that proponents say could help treat severe seizure [...]

[...] Cuomo has a separate, more limited plan, but now the governor is announcing the start of clinical trials for cannabidiol, a marijuana or hemp derivative that is being tried as a treatment for [...]

[...] Epidiolex, and the company said that it is on track to begin a Phase 2/3 clinical trial in Dravet syndrome in the second half of this year. The company further said about another indication: In [...]

[...] drug designation for its pharmaceutical derived Cannabidiol drug as a potential treatment for Dravet Syndrome. Insys Therapeutics, Inc. (NASDAQ: INSY), is a specialty pharmaceutical company that is [...]

[...] up before the reveal. GWP – Before the crash “LONDON, June 25, 2014 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc ( GWPH) (GWP.L) ("GW" or the "Company"), a biopharmaceutical [...]

[...] up before the reveal. GWP – Before the crash “LONDON, June 25, 2014 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc ( GWPH) (GWP.L) ("GW" or the "Company"), a biopharmaceutical [...]

[...] spray. Nabiximols (trade name Sativex) is a patented cannabinoid mouth spray developed by GW Pharmaceuticals for multiple sclerosis (MS) patients, who can use it to alleviate neuropathic pain , [...]

[...] by David Posel - June 23, 2014 GW Pharmaceuticals has teamed up with New York State and Gov. Andrew Cuomo to create what is now an FDA Fast [...]

[...] state laws went into effect Tuesday, but one could plant a seed for the Tennessee's future. Industrial hemp is now legal, though the state Department of Agriculture which will oversee it has yet to [...]

[...] industry. To further complicate matters, the Drug Enforcement Agency still considers industrial hemp a controlled substance even though it is not psychoactive. But times are changing. On [...]

[...] based CBD drugs. Quite often, media is not reporting on the fact that Cannabidiol from industrial hemp is not a controlled substance, but rather a basic food ingredient with no known side effects [...]

[...] on a 0-10 Numerical Rating Scale (p=0.004; 95% CI: -1.59, -0.32).  Improvements in Neuropathic Pain Scale composite score (p=0.007), sleep NRS (p=0.001), dynamic allodynia (p=0.042), punctate [...]

[...] remedies like ArisiTol. Today’s patients look for relief from not only the physical and neuropathic pain, but clearing the mental cloud and eliminating the often severe physical side effects of [...]

[...] by GW Pharmaceuticals for multiple sclerosis (MS) patients, who can use it to alleviate neuropathic pain , spasticity, overactive bladder, and other symptoms. Nabiximols is also being developed in [...]

[...] as well. Source Article People are lining up at some retailers and small online stores to buy CBD Products, which has become the newest heat wave in modern medicinal advancements that doesn't include [...]

[...] supplement retailers and organic cooperatives have begun selling ArisiTol ahead of other CBD products, with national sales trends pulling upwards at a rapid pace. This new Cannabidiol product by [...]

[...] call and make a switch." While there are some questions on a handful of inferior CBD products, Industry Watchdog ICOMR is heavy on testing, and light on the propaganda. Consumer interest [...]

[...] must also receive approval from various federal agencies, including the US Food and Drug Administration, Public Health Service, the US Drug Enforcement Administration, and the National Institute [...]

[...] on their existing stable analgesia. A self-titrating regimen was used to optimise drug administration. Sixty-three patients were randomised to receive sativex and 62 placebo. The mean [...]

by Jim Stingl | JS Online The approval of a marijuana derivative to ease seizure disorders in children came surprisingly fast in the state [...]

[...] ‘make you high’. With such an amazing list of benefits, I am absolutely convinced that CBD Cannabidiol is the supplement of the century. We are still offering a free week’s supply to every [...]